Company: BGLC
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001477932-25-008757
Chunk: 61

Company: BioNexus Gene Lab Corp
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 61
---
 Corporation of any applicable law or regulation.

7.18 Severability. If any part of the Plan is declared by any court of governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any other part of the Plan. Any Section or part of a Section so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section to the fullest extent possible while remaining lawful and valid.

7.19 No Funding. The Plan shall be unfunded. The Corporation shall not be required to establish any special or separate fund or to make any other segregation of funds or assets to ensure the payment of any Award. Prior to receipt of Shares or a cash distribution pursuant to the terms of an Award, such Award shall represent an unfunded unsecured contractual obligation of the Corporation and the Participant shall have no greater claim to the Shares underlying such Award or any other assets of the Corporation or Affiliate than any other unsecured general creditor.

<div align='center'>***</div>

| A-17 |

<div align='center'>Control Number: Number of Shares: Shareholder:

BIONEXUS GENE LAB CORP.

Unit A-28-7, Tower A, Menara UOA Bangsar

No. 5 Jalan Bangsar Utama1

59000 Kuala Lumpur, Malaysia

PROXY CARD

Solicited on Behalf of the Board of Directors for Annual Meeting of Shareholders - December 24, 2025

The undersigned hereby appoints Su-Leng Tan Lee, as proxy with full power of substitution, to represent and vote as set forth herein all the common shares of BioNexus Gene Lab Corp. which the undersigned is entitled to vote at the Annual Meeting of Shareholders and any adjournments or postponements thereof, as designated below.

If no designation is made, the proxy, when properly executed, will be voted “FOR” in Item 1, 2, 3, 4.</div>

Item 1 Each of Su-Leng Tan Lee, Muhammad Azrul bin Abdul Hamid, Jook Yuen Low, and Chee Keong Yap (being each director of the Company that held that office seven days before the date of the distribution of the notice of an annual meeting) is re-elected as a director of the Company.

| Su-Leng Tan Lee                |     | ☐ | FOR |     | ☐ | AGAINST |     | ☐ | ABSTAIN |
|